首页> 外文期刊>American Journal of Physiology >Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide.
【24h】

Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide.

机译:一氧化氮对肾小管肾反馈的依赖性调节。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Nonselective inhibition of nitric oxide (NO) synthase (NOS) augments myogenic autoregulation, an action that implies enhancement of pressure-induced constriction and dilatation. This pattern is not explained solely by interaction with a vasoconstrictor pathway. To test involvement of the Rho-Rho kinase pathway in modulation of autoregulation by NO, the selective Rho kinase inhibitor Y-27632 and/or the NOS inhibitor N(omega)-nitro-l-arginine methyl ester (l-NAME) were infused into the left renal artery of anesthetized rats. Y-27632 and l-NAME were also infused into isolated, perfused hydronephrotic kidneys to assess myogenic autoregulation over a wide range of perfusion pressure. In vivo, l-NAME reduced renal vascular conductance and augmented myogenic autoregulation, as shown by increased slope of gain reduction and associated phase peak in the pressure-flow transfer function. Y-27632 (10 mumol/l) strongly dilated the renal vasculature and profoundly inhibited autoregulation in the absence or presence of l-NAME in vivo and in vitro. Afferent arteriolar constriction induced by 30 mmol/l KCl was reversed (-92 +/- 3%) by Y-27632. Phenylephrine caused strong renal vasoconstriction but did not affect autoregulation. Inhibition of neuronal NOS by N(5)-(1-imino-3-butenyl)-l-ornithine (l-VNIO) did not cause significant vasoconstriction but did augment myogenic autoregulation. Thus vasoconstriction is neither necessary (l-VNIO) nor sufficient (phenylephrine) to explain the augmented myogenic autoregulation induced by l-NAME. The effect of l-VNIO implicates tubuloglomerular feedback (TGF) and neuronal NOS at the macula densa in regulation of the myogenic mechanism. This conclusion was confirmed by the demonstration that systemic furosemide removed the TGF signature from the pressure-flow transfer function and significantly inhibited myogenic autoregulation. In the presence of furosemide, augmentation of myogenic autoregulation by l-NAME was significantly reduced. These results provide a potential mechanism to explain interaction between myogenic and TGF-mediated autoregulation.
机译:一氧化氮(NO)合酶(NOS)的非选择性抑制作用增强了肌源性自调节作用,该作用暗示了压力诱导的收缩和扩张的增强。不能仅通过与血管收缩途径的相互作用来解释这种模式。为了测试Rho-Rho激酶途径参与NO调控自身调节的作用,注入了选择性Rho激酶抑制剂Y-27632和/或NOS抑制剂N(ω)-硝基-1-精氨酸甲酯(l-NAME)进入麻醉大鼠的左肾动脉。还将Y-27632和l-NAME注入隔离的,灌注的肾积水肾脏中,以评估在较宽的灌注压力范围内的肌源性自身调节作用。在体内,l-NAME降低了肾血管的传导性,并增强了肌源性自动调节,如增益减少的斜率增加和压力-流量传递函数中相关的相峰增加所表明。 Y-27632(10μmol/ l)在体内和体外均不存在或存在l-NAME的情况下,会强烈扩张肾血管,并显着抑制自身调节。 Y-27632使30 mmol / l KCl引起的传入小动脉收缩逆转(-92 +/- 3%)。苯肾上腺素引起强烈的肾血管收缩,但不影响自身调节。 N(5)-(1-亚氨基-3-丁烯基)-1-鸟氨酸(1-VNIO)对神经元NOS的抑制作用不会引起明显的血管收缩,但会增加肌原性自身调节作用。因此,血管收缩既不是必要的(1-VNIO),也不是充分的(去氧肾上腺素)来解释由1-NAME诱导的增强的肌原性自身调节。 I-VNIO的作用牵涉到黄斑区的肾小管肾小球反馈(TGF)和神经元NOS,从而调节成肌机制。该结论得到了以下证实:全身性速尿清除了压力-流量传递函数中的TGF标志,并显着抑制了肌源性自身调节。在呋塞米的存在下,l-NAME对肌源性自动调节的增强作用明显降低。这些结果提供了潜在的机制来解释成肌和TGF介导的自动调节之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号